Antihypertensive treatment with moexipril plus HCTZ vs metoprolol plus HCTZ in patients with mild-to-moderate hypertension

Journal of Human Hypertension

Volumn 11, Issue 2, 1997, Pages 133-137

  Stimpel, M ^a   Koch, B ^a  

^a Schwarz Pharma AG   (Germany)

Author keywords

High blood pressure; Hydrochlorothiazide; Metoprolol; Moexipril

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; METOPROLOL; MOEXIPRIL; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BACKACHE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; FATIGUE; FEMALE; FLU LIKE SYNDROME; HEADACHE; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEMOPTYSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PAIN; RANDOMIZED CONTROLLED TRIAL; RASH; SOMNOLENCE; SPHYGMOMANOMETRY; SYNCOPE; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TIME; UPPER RESPIRATORY TRACT INFECTION; VERTIGO;

EID: 0030984949     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000390     Document Type: Article

References (31)

1. Dahlof B et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338 (8778): 1281-1285.
2. Mann SJ. Systolic hypertension in the elderly. Pathophysiology and management. Arch Intern Med 1992; 152 (10): 1977-1984.
3. Tifft CPI, Chobanian AV. Are some antihypertensive therapies more efficacious than others in preventing complications and prolonging life? Hypertension 1991; 18 (Suppl 3): 146-152.
4. Cruickshank JM. The case for beta-blockers as first-line antihypertensive therapy. J Hypertens 1992; 10 (3): 21-27.
5. Vlasses PH et al. Comparative antihypertensive effects of enalapril maleate and hydrochlorothiazide, alone and in combination. J Clin Pharmacol 1983; 23: 227-233.
6. Reid JL. Pharmacokinetic and pharmacodynamic aspects of the choice of components of combination therapy. J Hum Hypertens 1995; 9 (Suppl 4): S19-S23.
7. Koch B, Stimpel M. Do patients with moderate hypertension profit from a combination therapy with moexipril plus HCTZ? Am J Hypertension 1996; 9: 159A.
8. Deget F, Brogden RN. Cilazapril: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease. Drugs 1991; 41 (5): 799-820.
9. Brunner HR et al. Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinations. J Hypertens 1990; 8: 3-11.
10. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of high blood pressure (JNC V). Arch Intern Med 1993; 153: 154-183.
11. Plosker GL, Sorkin EM. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders. Drugs 1994; 48 (2): 227-252.
12. Thurston H. Angiotensin-converting enzyme inhibition as first-line treatment for hypertension. Clin Exp Pharmacol Physiol Suppl 1992; 19: 67-71.
13. Noble S, Sorkin EM. Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension. Drugs 1995; 49 (5): 750-766.
14. Frampton JE, Peters DH. Ramipril. An updated review of its therapeutic use in essential hypertension and heart failure. Drugs 1995; 49 (3): 440-466.
15. Dahlof B, Hosie J. Antihypertensive efficacy and toler-ability of a fixed combination of metoprolol and felodipine in comparison with the individual substances in monotherapy, J Cardiovasc Pharmacol 1990; 16 (6): 910-916.
16. Frewin DB et al. A general-practice study of the efficacy and tolerability of metoprolol in mild essential hypertension. Med J Aust 1988; 148 (1): 31-35.
17. Stimpel M, Koch B, Persson B. Treatment of hypertension in elderly patients: Comparison of moexipril to hydrochlorothiazide. Pharmacol Res 1995; 31 (Suppl): 328.
18. Stimpel M, Koch B, Lucas CP. Withdrawal study to evaluate the efficacy and safety of moexipril in patients with mild to moderate hypertension. Ricerca Scientifica ed Educazione Permanente Supplemento n. 1995; 103: 185-186.
19. White WB, Fox AAL, Stimpel M. Long-term efficacy and safety of moexipril in the treatment of hypertension. J Hum Hypertens 1994; 8: 917-921.
20. Lind L, Pollare T, Berne C, Lithell H. Long-term metabolic effects of antihypertensive drugs. Am Heart J 1994; 128 (6Pt1): 1177-1183.
21. Middeke M et al. Normalization of lipid metabolism after withdrawal from antihypertensive long-term therapy with beta blockers and diuretics. Arteriosclerosis 1990; 10 (1): 145-147.
22. Holzgreve H, Middeke M. Concomitant considerations in long-term antihypertensive treatment. J Hum Hypertens 1990; 4 (Suppl 5): 11-18.
23. Louis WJ et al. Role of metabolic risk factors in cardiovascular prognosis of systemic hypertension. Am J Cardiol 1990; 65 (17): 43H-45H.
24. Calo L et al. Is hydrochlorothiazide-induced hypocalciuria due to inhibition of prostaglandin E2 synthesis? Clin Sci 1990; 78 (3): 321-325.
25. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321 (13): 868-873.
26. Ramsay LE, Yeo WW, Jackson PR. Metabolic effects of diuretics. Cardiology 1994; 84 (Suppl 2): 48-56.
27. Prichard NC, Owens CWI, Woolf AS. Adverse reactions to diuretics. European Heart Journal 1992; 13 (Suppl G): 96-103.
28. Morice AH, Brown MJ, Higenbottam T. Cough associated with angiotensin converting enzyme inhibition. J Cardiovasc Pharmacol 1989; 13 (Suppl 3): S59-S62.
29. Uzuballis RI, Frewin DB, Bushell MK, McEvoy RD. The effect of angiotensin converting enzyme inhibitors (ACE-1) and selective beta 1-antagonists on bronchial reactivity and the cough reflex in man. Eur J Clin Pharmacol 1989; 37 (5): 467-470.
30. Strocchi E, Valtancoli G, Ambrosioni E. The incidence of cough during treatment with angiotensin converting enzyme inhibitors. J Hypertens 1989; 7 (Suppl 6): S308-S309.
31. Fuller RW. Cough associated with angiotensin-converting enzyme inhibitors, J Hum Hypertens 1989; 3 (Suppl 1): 159-161.